Daptomycin non-susceptible Staphylococcus aureus at a US medical centre

被引：9
|
作者：
Velazquez, A. [1 ]
DeRyke, C. A. [2 ]
Goering, R. [3 ]
Hoover, V. [4 ]
Wallace, M. R. [1 ]
机构：
[1] Orlando Hlth, Infect Dis, Orlando, FL 32806 USA
[2] Orlando Hlth, Pharm, Orlando, FL 32806 USA
[3] Creighton Univ, Sch Med, Omaha, NE USA
[4] Orlando Hlth, Microbiol, Orlando, FL 32806 USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2013年 / 19卷 / 12期
关键词：
Antibiotic resistance; daptomycin; daptomycin resistance; staphylococcus aureus treatment; vancomycin; METHICILLIN-RESISTANT; BETA-LACTAMS; STRAINS; CEFTAROLINE; BACTEREMIA; VANCOMYCIN; INCREASE; PERIOD;
D O I：
10.1111/1469-0691.12171
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Daptomycin non-susceptible Staphylococcus aureus was rarely encountered at our medical centre until 2010, when 10 isolates (0.4% of S.aureus) were confirmed by E-test as non-susceptible. These isolates were not of the same strain type and there was no link between the 10 patients. Daptomycin non-susceptibility may be increasing.
引用
收藏
页码：1169 / 1172
页数：4
相关论文
共 50 条
  • [1] Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus
    Hutton, Mary A.
    Sundaram, Ayesha
    Perri, Mary B.
    Zervos, Marcus J.
    Herc, Erica S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 98 (03)
  • [2] Increasing rate of daptomycin non-susceptible strains of Staphylococcus aureus in patients with atopic dermatitis
    Blazewicz, Izabela
    Jaskiewicz, Maciej
    Piechowicz, Lidia
    Neubauer, Damian
    Nowicki, Roman J.
    Kamysz, Wojciech
    Baranska-Rybak, Wioletta
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2017, 34 (06): : 547 - 552
  • [3] Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
    Steed M.E.
    Hall A.D.
    Salimnia H.
    Kaatz G.W.
    Kaye K.S.
    Rybak M.J.
    Infectious Diseases and Therapy, 2013, 2 (2) : 187 - 200
  • [4] Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
    Murthy, Madhukiran H.
    Olson, Michael E.
    Wickert, Robert W.
    Fey, Paul D.
    Jalali, Ziba
    JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 57 (08) : 1036 - 1038
  • [5] Identification and comparison of risk factors for daptomycin non-susceptible S. aureus (DNS) and daptomycin non-susceptible Enterococcus (DNE)
    Cimino, Christo
    Slain, Douglas
    LaSala, Paul
    Keller, Lisa
    PHARMACOTHERAPY, 2015, 35 (11): : E275 - E275
  • [6] VISA-Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin
    Saravolatz, Louis D.
    Pawlak, Joan
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (02) : 159 - 161
  • [7] Phenotypic and genetic characterization of daptomycin non-susceptible Staphylococcus aureus strains selected by adaptive laboratory evolution
    Xu, Yanlei
    Xiao, Yanghua
    Zhao, Huilin
    Wang, Bingjie
    Yu, Jingyi
    Shang, Yongpeng
    Zhou, Ying
    Wu, Xiaocui
    Guo, Yinjuan
    Yu, Fangyou
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [8] Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature
    Sanjiv M. Baxi
    Dominic Chan
    Vivek Jain
    Infection, 2015, 43 : 751 - 754
  • [9] Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature
    Baxi, Sanjiv M.
    Chan, Dominic
    Jain, Vivek
    INFECTION, 2015, 43 (06) : 751 - 754
  • [10] Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
    Ejaz, Mohammad
    Syed, Muhammad Ali
    Jackson, Charlene R.
    Sharif, Mehmoona
    Faryal, Rani
    ANTIBIOTICS-BASEL, 2023, 12 (06):
12345